Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-19T19:57:40.565Z Has data issue: false hasContentIssue false
  • English
  • Français

Evidence-based medicine and routine clinical practice: the case of new antidepressant drugs

Published online by Cambridge University Press:  11 October 2011

Corrado Barbui
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Epidemiology and Psychiatric Sciences , Volume 11 , Issue 3 , September 2002 , pp. 152 - 158
Copyright
Copyright © Cambridge University Press 2002

References

BIBLIOGRAFIA

Anderson, I.M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders 58, 19–36.CrossRefGoogle ScholarPubMed
Anderson, I.M. & Tomenson, B.M. (1995). Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal 310, 1433–1438.Google Scholar
Barbui, C. & Hotopf, M. (2001a). Amitriptyline versus the rest: still the leading antidepressant after 40 years of randomised controlled trials. British Journal of Psychiatry 178, 129–144.Google Scholar
Barbui, C. & Hotopf, M. (2001b). 40 years of antidepressant drug trials. Acta Psychiatrica Scandinavica 104, 92–95.Google Scholar
Barbui, C., Hotopf, M, Freemantle, N., Boyton, J., Churchill, R., Eccles, M.P., Geddes, J.R., Hardy, R., Lewis, G. & Mason, J.M. (2000). Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. In The Cochrane Library, Issue 4. Update Software: Oxford.Google Scholar
Barbui, C., Campomori, A., Mezzalira, L., Da Cas, R. & Garattini, S. (2001). Psychotropic drug use in Italy 1984-1999: impact of regulatory changes. International Clinical Psychopharmacology 16, 227–233.Google Scholar
Hotopf, M., Hardy, R. & Lewis, G. (1996). Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 170, 120–127.Google Scholar
Keller, M.B. & Lavori, P.W. (1988). The adequacy of treating depression. Journal of Nervous and Mental Disease 176, 471–474.Google Scholar
Knottnerus, A. & Dinant, G.J. (1997). Medicine based evidence, a pre-requisite for evidence based medicine. British Medical Journal 315, 1109–1110.Google Scholar
Montgomery, S.A. & Kasper, S. (1995). Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psycliopharmacology 9, 33–40.CrossRefGoogle ScholarPubMed
Munizza, C., Tibaldi, F. & Bollini, P. (1995). Prescription pattern of antidepressants in out-patient psychiatric practice. Psychological Medicine 25, 771–778.CrossRefGoogle ScholarPubMed
Ohayon, M.M., Caulet, M., Priest, R.G. & Guilleminault, C. (1998). Psychotropic medication consumption patterns in the UK general population. Journal of Clinical Epidemiology 150, 571–577.Google Scholar
Pietraru, C., Barbui, C., Poggio, L. & Tognoni, G. (2001). Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. European Journal of Clinical Pharmacology 57, 605–609.Google Scholar
Rouillon, F., Blachier, C., Dreyfus, J.P., Bouhassira, M. & Allicar, M.P. (1996). Pharmaco-epidemiology study of the use of antidepressant drugs in the general population. Encephale 1, 39–48.Google Scholar
Simon, G.E., Wagner, E.H. & VonKorff, M. (1995). Cost-effectiveness comparisons using “real-world” randomised trials: the case of new antidepressant drugs. Journal of Clinical Epidemiology 48, 363–373.CrossRefGoogle ScholarPubMed
Simon, G.E., VonKorff, M., Heiligenstein, J.H., Revicki, D.A., Grothaus, L., Katon, W. & Wagner, E.H. (1996). Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. Journal of the American Medical Association 275, 1897–1902.Google Scholar
Simon, G.E., Heiligenstein, J.H., Revicki, D.A., VonKorff, M., Katon, W., Ludman, E., Grothaus, L. & Wagner, E.H. (1999). Long-term outcomes of initial antidepressant drug choice in a “real-world” randomised trial. Archives of Family Medicine 8, 319–325.Google Scholar
Song, F., Freemantle, N., Sheldon, T.A., House, A., Watson, P., Long, A., & Mason, J. (1993). Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal 306, 683–687.Google Scholar
Zimmerman, M., Mattia, J.I. & Posternack, M.A. (2002). Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry 159, 469–473.CrossRefGoogle ScholarPubMed